PK Studies

Unwavering quality in PK studies

Animal PK studies are valuable tools for screening compounds during the candidate optimization stage of drug discovery. PK studies provide valuable information on compounds including exposure, AUC, clearance, and half-life, etc. Proper PK studies can help speed up discovery, and ensure only compounds with desirable PK profiles are advanced into the clinic.

At PharmaLegacy, we perform whole ranges of animal PKs with species ranging from rodents to non-human primates (NHPs). We have more than a decade of experience servicing clients worldwide. Our vivarium is AAALAC accredited.

Contact Us


WT Mouse: CD-1, C57BL/6, BALB/c, Nude Mouse

Transgenic Mouse

Rat: SD, Wistar Han

Guinea Pig


Case Study: Large Molecule PK in Mouse

Case Study: Cassette Dosing PK in Mouse

Dog: Beagle

Monkey: Cynomolgus

Rabbit: New Zealand

Minipig: Bama

Case Study: Large Molecule PK in Monkey

Single Dose

Repeat Dose

Intravenous (Bolus and Infusion)

Oral (Solution, Suspension, Tablet, Capsule)








5 working days for single period studies for 90% of studies.

AUC, Half-life, Clearance, etc.

PK Calculation with WinNonlin

Extensively validated preclinical models:

  • Completed over 400 FDA / CFDA IND filings
  • Scientific staff with an average of over 15 years of experience in pharmacology
  • PK/PD, molecular pharmacology and preliminary toxicology adjacency studies
  • Capacity to house over 30,000 rodents and large animals

Work with the CRO that has the most experience in pharmacology. Work with PharmaLegacy.

Contact Us

DMPK studies demand flexibility. Can yours meet their goals?

When it comes to DMPK, flexibility is paramount. The right assay and instrumentation are all critical to ensuring you can meet your study goals and obtain meaningful, clinically relevant data.

Download our DMPK brochure and see how PharmaLegacy is equipped to ensure you get the answers you need, no matter how challenging the study.

    Screenshot 2024-01-09 021816

    We’re ready when you are.

    Tell us your pharmacology challenges.